Excitement about a potential new treatment for the coronavirus disease 2019 (COVID-19) pandemic currently engulfing the world is causing problems for patients with arthritis and systemic lupus erythematosus (SLE), who routinely use the drug to control their symptoms. 
Despite the absence of strong evidence about the efficacy of hydroxychloroquine against Covid-19, some people are already attempting to self-medicate with the drug, with disastrous consequences. Hydroxychloroquine can...

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:




Today, the FDA stood up a new program to expedite the development of potentially safe and effective life-saving treatments. The program, known as the Coronavirus Treatment Acceleration Program (CTAP), is using every tool at the agency’s disposal to bring new therapies to sick patients as quickly as possible, while at the same time su...

The coronavirus disease 2019 (COVID-19) pandemic will have a large impact in low-resource settings (LRS). 20% of COVID-19 patients become critically ill with hypoxia or respiratory failure. Critical illness, describing any acute life-threatening condition, is receiving increased attention in global health because of its large disease burden and population impact. Before the COVID-19 pandemic, growing evidence suggested that the care of critical illness was overlooked in LRS—hospitals cann...

The coronavirus disease 2019 (COVID-19) outbreak, which started in the Hubei province of China in 2019, has now spread to all continents, affecting 177 countries by March 27, 2020. Successful efforts in containing the COVID-19 virus in Asia resulted in WHO declaring Europe as the epicentre of the disease on March 13. Whether warmer temperatures will slow the spread of the COVID-19 virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a point of muc...

As part of the Trump Administration’s all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments. The program, known as the Coronavirus Treatment Acceleration Program (CTAP), is using every tool at the agency’s disposal to bring new therapies to sick patients as quickly as possible, while at the same ...

WHO is gathering the latest scientific findings and knowledge on coronavirus disease (COVID-19) and compiling it in short courses.  

You can search all WHO courses of coronavirus disease (COVID-19).

Click here for reference

Motivation isn’t a switch that you can turn on or off. At the hospital you’ve probably found that motivation comes pretty easily when everything is doing well, and your efforts are rewarded with cured patients. When you have important issues, like the COVID-19 crisis we're having, however, it’s not always that easy. You might be expected to take on additional responsibilities and pull "extra - extra - extra" hours, but without the recognition and compensation that you would have recei...

International Center for Numerical Methods in Engineering (CIMNE) researchers are applying computational fluid dynamics models coupled with particle-based models to the simulation of the flow of virus in the air produced by a sneeze. This research is carried out in close cooperation with the group of Professor Rainald Lohner at George Mason University in the USA. Prof Lohner, who is also the PI in this research activity, is an affiliated scientist to CIMNE where he spends 2-3 months resea...

AbstractThe world is going through a life-threating, a war-like, virus attack called COVID-19. Since its inception in the last four months, it has been increased ten times every two weeks outside mainland China. In this case, we address this challenging human crisis with a focus on the early discovery of coronavirus asymptomatic patients which would help to reduce the cross-infection of COVID-19 that estimates to attack at least 60% of the world population, according to WHO (2020). This p...

In these unprecedented times, HP is researching for the development of applications that can be helpful during the present situation caused by the Covid-19 pandemic. Additive manufacturing plays a decisive role, now more than ever, in providing fast and effective solutions that help us to protect our community. Together, with the global digital manufacturing community, they are mobilizing the technology, experience, and production capacity to help deliver critical part...

Via The Guardian, Julia Kollewe write: Oxford firm to screen 15,000 drugs in search for coronavirus cureExscientia to use AI to hunt through compounds which have passed human trials
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19.

Exscientia, a spinoff company from the University of Dundee that is now based in Oxford s...

Is the anti-flu drug Avigan effective in treating Covid-19? Lately, there has been a lot of media speculations around the Japanese favipiravir and its effectiveness against SARS-CoV-2. Chinese officials announced in a press conference that the drug could effectively treat this virus. A clinical trial from Chinese experts proving its validity has become available, but the results should be interpreted with caution. 
The open-label non-randomized control study proves that from the patien...